E-Buy Home, Inc. (EBYH)

[Bansky]

Strainsforpains, Inc. Announces Shareholder Updates (NY, NY)-(May 24, 2023)-(Strainsforpains,
Inc.)-
(OTC Markets :EBYH).

We are delighted to inform our shareholders that the company will be launching its App for the iOS
Apple platform in June 2023. The official debut will take place at the 33rd Annual International
Cannabinoid Research Society 2023 Symposium, scheduled to be held in Toronto, Canada from June 24-
29 at the Marriot Toronto Eaton Centre.

Our company has actively engaged in collaborations with various organizations to enhance its growth
strategy. These collaborations include expansion plans with Popped, a cannabis retail operation
based in NY, Teva Pharmaceuticals, an international pharmaceutical company headquartered in Tel
Aviv, Israel, and Mt. Sinai/NYU Hospitals' pain management division, a health organization based in
New York.

Collaborative efforts with organizations like Teva involve expanding our innovative ideas and
focusing on core therapeutic areas that offer the best opportunities for growth and excellence. We
are committed to leveraging our technology and data in conjunction with organizations possessing
unmatched technological and clinical expertise, with a specific emphasis on pursuing high-value
opportunities.

Furthermore, the company will continue its efforts to launch its own branded products that utilize
cannabis and health-based formulas. These products will be developed and sold through medical
dispensaries, such as Columbia Care, renowned for their strong brand names and reputations.

Mr. Shainberg, Strainsforpain's CEO, stated, "We are thrilled to be collaborating with outstanding
companies. Through leasing our Pennsylvania space, our research collaborations, and our agreements
for health product placement, we will generate additional revenue, expand our reach in the health
product market, and access a new customer base."

Overview of Strainsforpains, Inc.: Please visit our website at http://www.strainsforpains.com/.
Strainsforpains, Inc. is an innovative healthcare data technology company located in New York, N.Y.
The Company's objectives are to provide doctors, nurses, dispensaries, and patients access to an APP
that will allow for an advanced determination of comparison of strains or brands of cannabis
combinations with major illnesses, in a user-friendly manner. The company owns a 6.5-acre facility
in Pennsylvania that will be used for CBD product production. Mr. Shainberg is a member of the
prestigious International Cannabinoid Research Society, https://icrs.co/

About International Cannabinoid Research Society. The organization is dedicated to scientific research
of cannabinoids. It has 1300 research scientists among its members. https://www.icrs2023.org/
About Teva. Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a global leader in generic
and innovative medicines with a portfolio consisting of over 3,500 products in nearly every
therapeutic area. Around 200 million people around the world take a Teva medicine every day and are
served by one of the largest and most complex supply chains in the pharmaceutical industry.
https://www.tevapharm.com/